Thymic carcinoma other imaging findings

Revision as of 14:53, 28 June 2019 by Marjan Khan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Thymic Carcinoma Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymic carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Thymic carcinoma other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Thymic carcinoma other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymic carcinoma other imaging findings

CDC on Thymic carcinoma other imaging findings

Thymic carcinoma other imaging findings in the news

Blogs on Thymic carcinoma other imaging findings

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Thymic carcinoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

Other imaging studies for thymic carcinoma include FDG PET scan. The standarized uptake value (SUV) in the FDG PET is much higher for the thymic carcinoma than thymoma, with a high sensitivity (84.6%) and specificity (92.3%).[1][2]DG (Fludeoxyglucose) PET is a useful image study that allows differentiation between a thymoma and thymic carcinoma. The standarized uptake value (SUV) in the FDG PET is much higher for the thymic carcinoma, with a high sensitivity (84.6%) and specificity (92.3%)

Other Imaging Findings

FDG PET

FDG (Fludeoxyglucose) PET is a useful image study that allows differentiation between a thymoma and thymic carcinoma. The standarized uptake value (SUV) in the FDG PET is much higher for the thymic carcinoma, with a high sensitivity (84.6%) and specificity (92.3%).[1][2]

References

  1. 1.0 1.1 Template:Citejournal
  2. 2.0 2.1 Thymic Carcinoma. Radiopaedia. http://radiopaedia.org/articles/thymic-carcinoma. Accessed on 3rd January 2016.